David Katz to Israel
This is a "connection" page, showing publications David Katz has written about Israel.
Connection Strength
0.848
-
Katz DE, Leibner G, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Using the Elixhauser risk adjustment model to predict outcomes among patients hospitalized in internal medicine at a large, tertiary-care hospital in Israel. Isr J Health Policy Res. 2023 Nov 01; 12(1):32.
Score: 0.224
-
Mendlovic J, Zalut T, Munter G, Merin O, Yinnon AM, Katz DE. Mixed effect of increasing outflow of medical patients from an emergency department. Isr J Health Policy Res. 2021 10 27; 10(1):59.
Score: 0.195
-
Mendlovic J, Weiss G, Da'as N, Yinnon A, Katz DE. Internal medicine patients admitted without COVID-19 during the outbreak. Int J Clin Pract. 2020 Dec; 74(12):e13630.
Score: 0.179
-
Katz DE, Friedman ND, Ostrovski E, Ravid D, Amrami N, Avivi D, Mengesha B, Zaidenstein R, Lazarovitch T, Dadon M, Marchaim D. Diabetic foot infection in hospitalized adults. J Infect Chemother. 2016 Mar; 22(3):167-73.
Score: 0.131
-
Leibner G, Katz DE, Esayag Y, Kaufman N, Brammli-Greenberg S, Rose AJ. Incorporating clinical and demographic data into the Elixhauser Comorbidity Model: deriving and validating an enhanced model in a tertiary hospital's internal medicine department. BMC Health Serv Res. 2024 Dec 05; 24(1):1523.
Score: 0.060
-
Kronenfeld N, Zilberman-Itskovich S, Lazarovitch T, Zaidenstein R, Saadon H, Maya T, Katz DE, Marchaim D. The impact of improper empirical usage of antipseudomonals on admission to an acute care hospital. J Glob Antimicrob Resist. 2020 09; 22:5-8.
Score: 0.043
-
Orr N, Katz DE, Atsmon J, Radu P, Yavzori M, Halperin T, Sela T, Kayouf R, Klein Z, Ambar R, Cohen D, Wolf MK, Venkatesan MM, Hale TL. Community-based safety, immunogenicity, and transmissibility study of the Shigella sonnei WRSS1 vaccine in Israeli volunteers. Infect Immun. 2005 Dec; 73(12):8027-32.
Score: 0.016